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Abstract
The transferrin receptor of bloodstream form Trypanosoma brucei is a heterodimer encoded by expression site associated
genes 6 and 7. This low-abundance glycoprotein with a single glycosylphosphatidylinositol membrane anchor and eight
potential N-glycosylation sites is located in the flagellar pocket. The receptor is essential for the parasite, providing its only
source of iron by scavenging host transferrin from the bloodstream. Here, we demonstrate that both receptor subunits
contain endoglycosidase H-sensitive and endoglycosidase H-resistant N-glycans. Lectin blotting of the purified receptor and
structural analysis of the released N-glycans revealed oligomannose and paucimannose structures but, contrary to previous
suggestions, no poly-N-acetyllactosamine structures were found. Overlay experiments suggest that the receptor can bind to
other trypanosome glycoproteins, which may explain this discrepancy. Nevertheless, these data suggest that a current
model, in which poly-N-acetyllactosamine glycans are directly involved in receptor-mediated endocytosis in bloodstream
form Trypanosoma brucei, should be revised. Sequential endoglycosidase H and peptide-N-glycosidase F treatment,
followed by tryptic peptide analysis, allowed the mapping of oligomannose and paucimannose structures to four of the
receptor N-glycosylation sites. These results are discussed with respect to the current model for protein N-glycosylation in
the parasite. Finally, the glycosylation data allowed the creation of a molecular model for the parasite transferrin receptor.
This model, when placed in the context of a model for the dense variant surface glycoprotein coat in which it is embedded,
suggests that receptor N-glycosylation may play an important role in providing sufficient space for the approach and
binding of transferrin to the receptor, without significantly disrupting the continuity of the protective variant surface
glycoprotein coat.
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Introduction
The tsetse-transmitted Trypanosoma brucei group of parasites
cause human African trypanosomiasis and nagana in cattle and
constitute a serious health problem for people and livestock in 36
countries of sub-Saharan Africa. T. brucei exists in the mammalian
host as the bloodstream form trypomastigote and in the midgut of
the tsetse fly vector as the procyclic form. The major surface
molecules of the bloodstream form parasite are the glycosylpho-
sphatidylinositol (GPI) anchored [1–4] and N-glycosylated [3–6]
variant surface glycoproteins (VSGs), 5610
6 homodimers of which
form a dense monolayer over the whole trypanosome [4]. The
ability of individual trypanosomes to switch expression from one
VSG gene to another gives rise to antigenic variation by which the
parasite population survives the host acquired immune response
[7]. Other less abundant glycoproteins are arranged either
apparently randomly within the VSG coat, like the invariant
glycoproteins ISG65 and ISG75 [8,9], while others have specific
surface locations, like Fla1 which locates to the flagellar adhesion
zone [10] and the transferrin receptor which locates to the flagellar
pocket [11]. Still other glycoproteins are located primarily in
intracellular sites, like lysosomal p67 [12], Golgi and lysosomal
tGLP1 [13], endoplasmic reticulum GPIdeAc [14] and endosomal
TbMBAP1 [15]. The surface of the procyclic form parasite is
dominated by 3610
6 copies of the GPI-anchored and N-
glycosylated procyclin glycoproteins [4,16,17], about 1610
6 free
GPI glycolipids [18,19] and a high-molecular weight glycoconju-
gate complex [20,21]. While this life cycle stage shares some
glycoproteins with the bloodstream form, like p67, tGLP1 and
Fla1, others are clearly bloodstream form specific, like ISG65,
ISG75, TbBMAP1 and the expression site associated gene (ESAG)
6 and ESAG7 subunits of the heterodimeric T. brucei transferrin
receptor (TfR).
Some of these glycoproteins are encoded by polygene families,
causing sequence heterogeneity in the populations expressed by
the trypanosomes. In the case of the TfR ESAG6/ESAG7
subunits, the ESAG6 and ESAG7 genes are associated with
telomeric VSG expression sites such that one dominant
ESAG6/ESAG7 pair dominates according to which site (and
VSG variant) is being expressed [22]. However, there is also some
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ESAG6 and ESAG7 genes are immediately adjacent to the
expression site promoters, providing some sequence heterogeneity
in all TfR preparations [23]. There is functional significance with
respect to which ESAG6/ESAG7 pair is expressed due to their
different affinities for transferrins from different mammalian
species [24,25]. While there are quite complete data on the GPI
anchor and N-glycan structures and N-glycosylation site occupan-
cies of specific VSGs and procyclins [1–6,17,26] and on the
structures of the total N-glycan repertoires of the bloodstream
form [27,28] and procyclic form [29,30] of the parasite, there is a
paucity of data of the glycosylation status of other specific T. brucei
glycoproteins. In this paper, we describe the N-glycosylation status
of the ESAG6 and ESAG7 subunits of the transferrin receptor
(TfR) and, together with our previous description of the GPI
anchor of the ESAG6 subunit [31], provide a relatively complete
description of the glycosylation status of this low abundance
(approximately 3000 copies per cell [32]) but nutritionally essential
[33] glycoprotein. The results are discussed in the context of
proposed mechanisms of protein N-glycosylation [34–37] and
endocytosis [38] in T. brucei. We also build a molecular model of
the glycosylated ESAG6/ESAG7 transferrin receptor, surrounded
by models of glycosylated VSG molecules, to visualize how this
receptor sits in the VSG coat on the flagellar pocket membrane
and how it might bind its transferrin ligand.
Results
Purification and endoglycosidase digestion of T. brucei
TfR
The transferrin receptor (TfR) was purified by affinity
chromatography on immobilized transferrin, following the method
first described by Steverding and Overath [39]. An aliquot was
analyzed by SDS-PAGE and silver staining, which showed the
characteristic ESAG6 and ESAG7 subunits (Figure 1A). The
identities of the ESAG6 and ESAG7 components were confirmed
by excision of the individual bands, in gel tryptic digestion and
proteomic analysis (data not shown). Endoglycosidase digests
confirmed that both ESAG6 and ESAG7 carry N-linked
oligosaccharides. Thus, digestion with both peptide N-glycosidase
F (PNGase F), an enzyme that cleaves essentially all types of N-
linked glycan, and Endoglycosidase H (Endo H), an enzyme that
cleaves only oligomannose-type N-glycans, reduced the apparent
Author Summary
The tsetse fly transmitted parasite that causes human
African trypanosomiasis, or sleeping sickness, scavenges
iron from the bloodstream of the infected individual so
that it can live, multiply and ultimately cause disease. To
do this, it places a glycoprotein (a protein with carbohy-
drate chains attached) called the transferrin receptor on its
surface to capture circulating human transferrin, an iron
transport protein. It then internalizes transferrin receptor/
transferrin complex and digests the transferrin part,
releasing the iron for its own use. By analyzing the parasite
transferrin receptor, we have been able to describe the
carbohydrate chains of the transferrin receptor and thus
complete a molecular model of this important glycopro-
tein. We have further built models of how we expect this
low abundance glycoprotein will sit in the surface coat of
the parasite, which is made of millions of copies of another
glycoprotein. The results provide a ‘molecule’s eye view’ of
how the carbohydrate chains of the transferrin receptor
provide the space necessary for the transferrin to bind to it
without disrupting the protective coat.
Figure 1. SDS-PAGE analysis of purified T. brucei TfR and endoglycosidase digestions. (A) An aliquot of T. brucei TfR, affinity purified on
transferrin-Sepharose, was analyzed by SDS-PAGE and silver staining. (B) Aliquots of purified TfR were incubated with Endo H (lane 1), PNGase F (lane
3) or mock treated (lane 2) and analyzed by SDS-PAGE and Western blot with an antibody that reacts with the ESAG6 and ESAG7 subunits of TfR.
doi:10.1371/journal.ppat.1002618.g001
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Western blotting with anti-TfR antibodies (Figure 1B). However,
PNGase F reduced the apparent molecular weights of both
proteins more than Endo H (Figure 1B, compare lanes 1 and 3),
suggesting that both proteins contain a mixture of Endo H-
sensitive (i.e., oligomannose) and Endo H-resistant (i.e., pauci-
mannose and/or complex) N-glycans. The heterogeneity still
apparent in ESAG6 following complete de-N-glycosylation with
PNGase F is presumably due to the reported heterogeneity in the
a-galactose side chains of the GPI anchor attached to this TfR
subunit [31].
Lectin blotting of T. brucei TfR
Aliquots of purified TfR were separated by SDS-PAGE, blotted
onto nitrocellulose and probed with anti-TfR antibody (Figure 2,
lane 1) and by lectins. Consistent with the presence of oligomannose
N-glycans, both ESAG6 and ESAG7 subunits gave a positive
reaction with concanavalin A (ConA) (Figure 2, lane 2), as did the
bovineribonucleaseBpositivecontrolglycoprotein(Figure2,lane4).
These reactions were abolished when a-methyl-mannose was
included in the blotting buffer (Figure 2, lanes 3 and 5),
demonstrating the carbohydrate specificity of the ConA blots.
However, neither of the ESAG subunits gave a significant reaction
with the poly-LacNAc-specific tomato lectin (Figure S1) or, more
importantly, with the far more permissive [40] N-acetyllactosamine
(LacNAc) specific lectin from Erythrina cristigalli (ErCr) (Figure 2, lane
6) or with the terminal b-galactose-specific lectin ricin (Figure 2, lane
10). These experiments were performed under conditions where a
strong reaction was seen against the positive control glycoprotein
bovine asialotransferrin (Figure 2, lanes 8 and 12) and where the
reactions with the ErCr and ricin lectins against the positive control
were abolished by the inclusion of lactose or galactose plus lactose,
respectively, in the blotting buffer (Figure 2, lanes 9 and 13). These
data suggest that the Endo H-resistant N-glycans of ESAG6 and
ESAG7 are not of the poly-LacNAc-containing complex type nor,
indeed, even of the LacNAc-containing complex type and are,
therefore, most likely of the paucimannose type.
Release, radiolabeling and analysis of T. brucei TfR N-
glycans
The lectin blotting experiments, described above, suggested that
ESAG6 and ESAG7 contain oligomannose and paucimannose N-
glycans. However, there remained the formal possibility that the
Endo H-resistant N-glycan fraction might include complex N-
glycans fully capped with terminal a-Gal residues, which could
abrogate ricin and ErCr lectin binding to the sub-terminal b-Gal
residues and LacNAc units, respectively, and for which there is
precedent in some VSG N-linked glycans [5]. Therefore, to
analyze the N-glycan structures further, total N-glycans were
released from TfR with PNGase F, radiolabeled by reduction with
NaB[
3H]4 and analyzed by high-performance thin layer chroma-
tography (HPTLC) alongside radiolabeled N-glycan standards
(Figure 3A). A ladder of bands was observed, stretching from the
position of Man9GlcNAc2 to Man5GlcNAc2, with two additional
bands of higher Rf, possibly corresponding to Man4GlcNAc2 and
Man3GlcNAc2 paucimannose species. Significantly, there were no
bands with Rf values consistent with complex N-glycans capped
with terminal a-Gal residues or with poly-LacNAc-containing N-
glycans, like those found in VSG variant MITat1.7 [5] (Figure S2).
The radioactive material at the origin of the TLC plate in
(Figure 3A) is present in all NaB[
3H]4-labeled samples, including
commercial glycan standards (Figure S2). A sample of the mixture
of labeled N-glycans was separated by Dionex high-pH anion
exchange chromatography (HPAEC) and three major radioactive
peaks were recovered (Figure S3). These were individually
analyzed by HPTLC alongside authentic radiolabeled N-glycan
standards and it was found that peak b and peak c co-migrated with
Man5GlcNAc2 by HPTLC, while peak a migrated ahead of
Man5GlcNAc2 and was assigned as a putative Man4GlcNAc2
structure (Figure 3B). Consistent with the latter assignment,
digestion of the peak a material with the Aspergillus saitoi Mana1-
2Man-specific a-mannosidase (ASaM) caused an increase in Rf
equivalent to the removal of a single hexose (Figure 3C, compare
lanes 1 and 2). In contrast, the majority of the material in the peak b
fraction was resistant to ASaM (Figure 3C, compare lanes 3 and
Figure 2. Lectin blots of purified TfR. Aliquots of purified T. brucei TfR (lanes 1, 2, 3, 6, 7, 10 and 11) and of bovine ribonuclease B, a positive
control for ConA blotting (lanes 4 and 5), and bovine asialotransferrin, a positive control for ErCr lectin and ricin blotting (lanes 8, 9, 12 and 13), were
separated by SDS-PAGE, transferred to nitrocellulose and subjected to blotting with anti-TfR antibody (lane 1), ConA (lanes 2–5), ErCr lectin (lanes6 –
9) or ricin (lanes 10–13) in the absence (2) or presence (+) of the competing sugars a-methyl-mannose (lanes 3 and 5), lactose (lanes 7 and 9) or
galactose and lactose (lanes 11 and 13). The positions of molecular weight markers are indicated for each group of blots.
doi:10.1371/journal.ppat.1002618.g002
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of the conventional oligomannose series. By inference, we assign
the peak c material as the bi-antennary Man5GlcNAc2 structure of
the paucimannose series and, indeed, a small component of the
peak b material does digest with ASaM to lose two hexose residues,
suggesting this is a small amount of bi-antennary Man5GlcNAc2
contamination from the adjacent peak c (Figure 3C, lane 4).
Unfortunately, there was insufficient radiolabeled purified peak c
material on which to perform a separate ASaM digest. The
proposed structures of the main N-glycan species are shown in
(Figure 3A). These structures are consistent with the data in
(Figure 3A–C) and also draw on our prior knowledge of the
structures of the oligomannose and paucimannose series in
bloodstream form T. brucei [5,6,28].
Analysis of TfR N-glycosylation site occupancy by LC-MS/
MS
The aforementioned endoglycosidase digestion results, lectin
blots and N-glycan structural analyses strongly suggest that
ESAG6 and ESAG7 contain both oligomannose and pauciman-
nose N-glycans, but not complex N-glycans. Previous work has
shown that bloodstream form T. brucei expresses two classes of
oligosaccharyltransferase (OST] activity [34–37]: One that
transfers Man5GlcNAc2 from Man5GlcNAc2-PP-Dol to N-glyco-
Figure 3. Fluorographs of HPTLC analyses of released and radiolabeled N-glycans from purified TfR. (A) Total N-glycan fraction of TfR
released by PNGase F and radiolabeled by reduction with NaB[
3H]4. The positions of oligomannose N-linked glycan standards reduced with NaB[
3H]4
are shown on the left. The proposed structures of the principal TfR glycans are shown on the right. The top three biantennary structures
(Man3GlcNAc2 to Man5GlcNAc2) are of the paucimannose series and the bottom three triantennary structures (Man5GlcNAc2 to Man7GlcNAc2) are of
the oligomannose series. (B) The three major components of the radiolabeled TfR N-glycan fraction isolated by Dionex HPAEC (peaks a, b and c; lanes
1, 2 and 3, respectively). The positions of NaB[
3H]4 reduced oligomannose N-linked glycan and dextran oligomer standards are shown on the left and
right, respectively. (C) The paucimannose Man4GlcNAc2 structure (Dionex peak a) before (lane 1) and after (lane 2) digestion with Mana1-2Man
specific a-mannosidase (ASaM) and the triantennary oligomannose Man5GlcNAc2structure Dionex peak b before (lane 3) and after (lane 4) digestion
with ASaM. The positions of NaB[
3H]4-reduced dextran oligomers are shown on right.
doi:10.1371/journal.ppat.1002618.g003
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transfers Man9GlcNAc2 from Man9GlcNAc2-PP-Dol to the
remaining N-glycosylation sequons. These activities are encoded
by the TbSTT3A and TbSTT3B genes, respectively [34]. We
therefore subjected purified TfR to Endo H digestion followed by
PNGase F digestion, resolved the double-digested ESAG6 and
ESAG7 by SDS-PAGE and performed in-gel tryptic digestion and
analyzed the resultant peptides by LC-MS/MS. Using this
protocol [34], peptides encompassing Endo H-sensitive (oligo-
mannose) N-glycosylation sites appear with a 203 Da shift, from
the single GlcNAc residue left attached to the Asn residue by Endo
H, and peptides encompassing Endo H-resistant (paucimannose)
N-glycosylation sites appear with a 1 Da shift, from the conversion
of Asn to Asp by PNGase F. Using this technique, we were able to
positively identify three of the five N-glycosylation sites of ESAG6
as occupied, one (Asn94) with Endo H-resistant paucimannose N-
glycans and two (Asn10 and Asn344) with Endo H-sensitive
oligomannose N-glycans. The pI values of these Asn-Xaa-Ser/Thr
sequons 65 amino acid residues are consistent with their
modification by TbSTT3A and TbSTT3B OST activities,
respectively [34] (Table 1). Peptides encompassing the remaining
two putative N-glycosylation sites, at Asn219 and Asn234, were
not observed but their surrounding sequences would suggest that
they are both modified by TbSTT3B OST and are likely to carry
oligomannose structures (Table 1). In the comparable ESAG7
analysis, we positively identify one (Asn10) of the three N-
glycosylation sites as occupied with Endo H-sensitive oligoman-
nose N-glycans, consistent with its modification by TbSTT3B.
Peptides encompassing the remaining two putative N-glycosylation
sites, at Asn94 and Asn218, were not observed but their
surrounding sequences would suggest that Asn94 is modified by
TbSTT3A OST and likely to carry paucimannose structures and
Asn218 is modified by TbSTT3B OST and likely to carry
oligomannose structures (Table 1). Representations of the
glycosylation of the ESAG6 and ESAG7 subunits of the TfR are
shown in (Figure 4). The proteomics analysis of the TfR
components (described above) also indicated that the principal
ESAG6 and ESAG7 sequences present the purified TfR
preparation corresponded to those deposited under accession
numbers CAQ57442.1 and CAQ57441.1, respectively.
TfR binds indirectly glycoproteins that might, in turn,
bind to tomato lectin
Nolan and colleagues that have reported that TfR can be
isolated from a trypanosome lysate with tomato lectin-Sepharose
[38]. However, we did not identify any tomato lectin (TL) binding
poly-LacNAc-containing N-glycans in either subunit of trypano-
some TfR. We therefore entertained the possibility that TfR binds
indirectly to TL through interaction with other glycoprotein(s) that
do bear poly-LacNAc-containing N-glycans. To investigate this,
we took osmotically lysed cells, depleted of VSG and TfR by the
action of endogenous GPI-PLC on their GPI anchors, and isolated
the total ricin-binding glycoprotein fraction, that includes the TL
binding glycoproteins as a significant sub-set [27], and separated
and immobilized them by SDS-PAGE and Western blot. The
presence of TL-binding glycoproteins was confirmed by probing
the blot with TL (Figure 5, lane 3) and the carbohydrate-specificity
of this signal was confirmed by inhibition with chitin hydrolysate
Figure 4. Glycosylation patterns of ESAG6 and ESAG7. Maps of the major N-glycan types at each N-glycosylation site along the polypeptide
backbones of ESAG6 and ESAG7, based on the data in Figure 3 and Table 1, and the GPI glycan structure of ESAG6, based on [31].
doi:10.1371/journal.ppat.1002618.g004
Table 1. Experimental and theoretical occupancy of TfR N-
glycosylation sites.
Site
1 Sequon pI
2 Endo H
3
Predicted Major
Glycan
4
ESAG6,Asn010 ERNALNATAANKV 8.85 E+ Oligomannose,
Man5GlcNAc2
ESAG6,Asn094 LEEMRNASALAAA 4.53 E2 Paucimannose,
Man4GlcNAc2
ESAG6,Asn219 SPTRHNLTWGGGV 9.49 P+ Oligomannose,
Man5GlcNAc2
ESAG6,Asn234 FGSYQNGSMYVEG 4.00 P2 Paucimannose,
Man4GlcNAc2
ESAG6,Asn344 TILKSNYTAEPVR 8.26 E+ Oligomannose,
Man5GlcNAc2
ESAG7,Asn010 ERNALNATAANKV 8.85 E+ Oligomannose,
Man5GlcNAc2
ESAG7,Asn094 LEEMRNASALAAA 4.53 P2 Paucimannose,
Man4GlcNAc2
ESAG7,Asn218 VCLNRNFTWGGGV 8.22 P+ Oligomannose,
Man5GlcNAc2
1Based on the predicted amino acid sequences for ESAG6 (GenBank:
CAQ57442.1) and ESAG7 (GenBank: CAQ57441.1) minus their predicted 17-
residue N-terminal signal peptides.
2Predicted isoelectric point of the glycosylation sequon 65 amino acid residues,
as shown, calculated using ExPASy Compute pI/MW.
3Experimentally determined (E) or theoretically predicted (P) sensitivity (+)o r
resistance (2) of the N-glycan to Endo H at the glycosylation site.
4The major triantennary Endo H sensitive oligomannose Man5GlcNac2 structure
is Mana1-3(Mana1-3(Mana1-6-Mana1-6)Manb1-4GlcNAcb1-4GlcNAc and the
major biantennary Endo H resistant paucimannose Man4GlcNac2 structure is
Mana1-2Mana1-3(Mana1-6Manb1-4GlcNAcb1-4GlcNAc.
doi:10.1371/journal.ppat.1002618.t001
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antibodies before and after pre-incubation with purified TfR.
Without pre-incubation with purified TfR, the anti-TfR blots were
devoid of significant signal (Figure 5, lane 1), whereas with pre-
incubation with purified TfR the anti-TfR blots showed two clear
bands at apparent molecular weights of around 55 kDa and
97 kDa. From these data we conclude that TfR is able to bind to
other glycoproteins that, in turn, can bind to ricin and therefore
possibly also to TL.
Molecular modeling of TfR in a VSG coat
Based on the widely accepted assumption that T. brucei TfR has
a similar tertiary structure and quaternary structure to the N-
terminal domain of VSG [41,42], for which there are crystallo-
graphic data [43], we have made a homology model of the
ESAG6/ESAG7 heterodimer of TfR and added to this represen-
tative N-linked glycan structures, according to the data and
predictions presented in this paper (Table 1 and Figure 4), and a
GPI anchor [31]. VSG MITat1.2 was modeled based on the
crystal structure of the N-terminal domain [43], the NMR
structure of the C-terminal domain [44], and representative N-
linked glycan and GPI anchor structures [2,5,35,36]. The N-
terminal and C-terminal domains were placed with relatively
compact linkers between the two domains and between the C-
terminal domain and the GPI anchor. With extended linkers the
two domains could be displaced significantly further from the
membrane. Human transferrin was modeled based on the
structure of iron-bound human transferrin in complex with the
human transferrin receptor [45] and representative N-linked [46]
and O-linked [47] glycans. The comparison between the models of
TfR and VSG MITat1.2 is shown (Figure 6A). A model of TfR
surrounded by VSG molecules at their expected surface density
[48] is also shown (Figure 6B). Into this model we have placed a
model of glycosylated human transferrin, in the same orientation
in which it docks to the human receptor [45] (Figure 6C).
Although the TfR model is based on the specific ESAG6 and
ESAG7 species found in our TfR preparation (accession numbers
CAQ57442.1 and CAQ57441.1), the highly conserved amino acid
sequences and glycosylation sites of the T. brucei brucei ESAG6 and
ESAG7 families (Table S1 and Table S2) suggests that it would be
reasonable to assume that this is a general model for all T. brucei
brucei ESAG6/ESAG7 heterodimers.
Discussion
As well as contributing to a three dimensional model of T. brucei
TfR, the experimental data on N-glycosylation site occupancy for
three of the five N-glycosylation sites of ESAG6 and one of the
three for ESAG7 presented in this paper (Table 1; Figure 4)
provide support for the model of a unique mechanism of protein
N-glycosylation in T. brucei [34–37]. According to this model, T.
brucei N-glycosylation sequons in relatively acidic environments
(like Asn94 of ESAG6) co-translationally receive exclusively (Endo
H-resistant) biantennary Man5GlcNAc2 through the action of an
oligosaccharyltransferase (OST) encoded by the TbSTT3A gene
whereas the remaining sites (like Asn10 and Asn344 of ESAG6
and Asn10 of ESAG7) are acted upon post-translationally by an
OST encoded by the TbSTT3B gene and receive exclusively (Endo
H-sensitive) triantennary oligomannose Man9GlcNAc2. Once
transferred to protein, the biantennary Man5GlcNAc2 structure
on the acidic sites may then be processed to paucimannose
(Man4GlcNAc2 and Man3GlcNAc2) structures with the latter, in
some cases, further elaborated to complex glycan structures.
Apparently this further processing to complex glycans does not
occur on ESAG6 or ESAG7, where Man4GlcNAc2 appears to be
the predominant endo H-resistant structure. The triantennary
oligomannose Man9GlcNAc2 structures at the non-acidic sites can
only be maximally processed to the triantennary oligomannose
Man5GlcNAc2 structure, which appears to be the predominant
endo H-sensitive structure on ESAG6 and ESAG7.
Another recent analysis of the single N-glycan of VSG
MITat.1.8 also supported the model in [34]. In this case, a single
acidic N-glycosylation site at Asn59 was found to be occupied
exclusively by a biantennery complex N-glycan structure of Gal
b1-4GlcNAcb1-2Mana1-3(Galb1-4GlcNAcb1-2Mana1-6)Manb1-
4GlcNAcb1-4GlcNAc. Presumably, and in contrast to the VSG
MITat.1.8 example, the acidic TfR N-glycosylation sites fail to be
processed beyond the trimming of up to two a1-2-linked mannose
residues due to steric constraints, reducing access by a-mannosi-
dases and preventing subsequent access by bGlcNAc-transferases.
It was suggested by Nolan and colleagues that T. brucei TfR
contains poly-LacNAc glycans because ESAG6 and ESAG7 in
whole cell detergent lysates bound to tomato lectin (TL) beads
[38]. These authors further suggested a tentative model for
endocytosis in trypanosomes, postulating an interaction between
poly-LacNAc N-glycans on TfR (and other receptors) and a
protein in the flagellar pocket with an extracellular TL lectin-like
domain and a cytoplasmic domain that interacts with the
machinery of the endocytic pathway. This model was supported
by an approximately 5-fold reduction in transferrin endocytic rate
when trypanosomes were incubated in 15 mM each of tri-N-
acetyl-chitotriose and tetra-N-acetyl-chitotetraose. However, our
data show that TfR does not contain any poly-LacNAc structures.
Therefore, a direct link between receptor-linked poly-LacNAc
glycans and endocytic machinery can be ruled out. However, we
Figure 5. TfR does not bind directly to tomato lectin but binds
to other glycoproteins. A ricin-binding glycoprotein fraction ([27]
was purified from T. brucei, separated by SDS-PAGE and transferred to
nitrocellulose. Identical lanes were incubated without (lane 1) or with
(lane 2) purified TfR, followed by anti-TfR antibody, or with tomato
lectin (TL) in the absence (lane 3) or presence (lane 4) of competing
chitin hydrolysate. The positions of molecular weight markers are
shown on the left.
doi:10.1371/journal.ppat.1002618.g005
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binding glycoproteins. Since the TL-binding glycoproteins of T.
brucei are a sub-set of the ricin-binding fraction [27], these data
may explain why TfR was found in the TL-binding fraction [38],
i.e., through the non-covalent association of TfR with other
glycoproteins. It should be pointed out that the association seen in
the TfR overlay experiment could be through protein-protein
and/or protein-carbohydrate interaction(s) and that, relevant to
possible protein-carbohydrate interactions, the glycoproteins in the
ricin-binding fraction contain oligomannose and paucimannose
glycans as well as conventional complex and poly-LacNAc
containing N-glycans. The latter two classes of glycan bind
directly to ricin while the former are present because many
glycoproteins contain a mixture of both oligomannose and/or
paucimannose and complex and/or poly-LacNAc glycans at-
tached to different glycosylation sites in the same polypeptide.
Figure 6. Molecular modeling of TfR in the VSG coat of T. brucei. (A) A single glycosylated ESAG6/ESAG7 TfR heterodimer is shown flanked by
two glycosylated VSG homodimers. The molecular models suggest that TfR is likely to be recessed into the VSG surface coat. (B) Top and side views of
a glycosylated TfR molecule surrounded by VSG molecules. (C) The same views as (B) but with a glycosylated transferrin molecule approaching the
TfR. TfR: peptide chains – green; N-glycans – yellow; GPI anchor – orange. VSG: peptide chains – blue; N-glycans – yellow; GPI anchor – orange.
Transferrin: peptide chains – red; N- and O-glycans – purple.
doi:10.1371/journal.ppat.1002618.g006
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could still be relevant for poly-LacNAc-mediated endocytosis in
theory, the normal in vitro growth rate of bloodstream form
trypanosomes under TbSTT3A RNAi knockdown [34], when the
synthesis of almost all complex N-glycans (including poly-LacNAc
glycans) is abrogated, also brings the model of poly-LacNAc-
mediated endocytosis into question. We therefore suggest that we
should return to a null hypothesis: That transferrin, captured by
the parasite TfR embedded in the VSG coat, is endocytosed
constitutively in clathrin-coated vesicles and that the extremely
rapid turnover of the flagellar pocket membrane in bloodstream
form T. brucei [49,50] provides a sufficient rate of uptake of this
(and other) essential macromolecular nutrients from host serum.
The molecular modeling of TfR alongside VSG shows that TfR
is predicted to sit low in the VSG coat. However, the N-glycans of
TfR significantly increase the surface area occupied by TfR
compared with VSG. This may be physiologically relevant since
the TfR glycans may contribute to protecting the underlying
plasma membrane from lytic host serum components while
providing sufficient space to allow access of the 80 kDa bi-lobed
transferrin glycoprotein, regardless of the relative orientations of
the receptor and the ligand (which are currently unknown) when
binding takes place. Thus, the widest diameter of transferrin is
significantly larger than that of aglycosyl TfR but similar to that of
glycosylated TfR. Previously, we had speculated that since the
single dimyristoyl-GPI anchor of the ESAG6/ESAG7 TfR
heterodimer (as compared to the twin dimyristoyl-GPI anchors
of VSG homodimers) would lead to relatively weak association of
TfR with the flagellar pocket membrane [51], this might allow
TfR to leave the membrane and dock with transferrin in the fluid
phase of the flagellar pocket [31]. While the molecular modeling
presented here does not altogether rule that model out, it does
suggest that the TfR does not de facto have to leave the membrane
to dock with its ligand.
Finally, one would predict that transferrin/TfR accessibility at
the flagellar pocket membrane is under extreme spatial constraint
to prevent complement activation by the underlying plasma
membrane. In other words, one would predict that TfR should be
able make sufficient space within the VSG coat to allow transferrin
to approach and be captured but without exposing significantly
more underlying plasma membrane than found throughout the
rest of the VSG coat. This tuning of the space occupied by TfR
appears to be satisfied by N-glycosylation of both of its subunits
and it may explain why TfR has so many N-glycosylation sites
(eight) compared to the structurally-related VSGs, which generally
have only two or four N-glycans per VSG dimer [4].
Materials and Methods
Ethics statement
Rodents were used to propagate sufficient T. brucei parasites for
the purification of sufficient transferrin receptor for high-sensitivity
structural analyses. The animal procedures were carried out
according the United Kingdom Animals (Scientific Procedures)
Act 1986 and according to specific protocols approved by The
University of Dundee Ethics Committee and as defined and
approved in the UK Home Office Project License PPL 60/3836
held by MAJF.
Purification of TfR
The transferrin receptor was purified from blood stream form
trypanosomes as previously described by Mehlert and Ferguson
[31] using affinity chromatography with transferrin-Sepharose
which was first described in [39].
Exoglycosidase digestion, SDS-PAGE and western
blotting of TfR
Exoglycosidase digests were carried out using both N-glycanase
F and Endoglycosidase H as described in Izquierdo et al [34]. The
exoglycosidase digests were analyzed by reducing SDS-PAGE with
4–12% gradient gels (Invitrogen), using MOPs buffer and then
Western blotting onto nitrocellulose (GE Healthcare) as in [28].
After blocking and incubating in rabbit polyclonal anti-transferrin
receptor (kindly supplied by Dietmer Steverding) at the dilution of
1 in 1000 then washing several times in blocking buffer, the
membranes were incubated in Anti-rabbit HRP at a dilution of 1
in 20,000. After further washing visualization of the bands was
achieved using ECL reagents (GE Healthcare).
Lectin blotting of TfR
SDS PAGE and Western blotting was carried out as above
and then the membranes were stained using lectins as described
in [34]. All lectin-biotin conjugates were obtained from Vector
laboratories. Concanavalin A conjugated to biotin was used at a
dilution of 1 in 3,000 (with or without 0.5 M a-methyl-mannose).
Ricin-biotin was used at a dilution of 1 in 3,000 (with or without
10 mg/ml galactose and 10 mg/ml lactose), tomato lectin-biotin
conjugate diluted was used at a dilution of 1 in 10,000 (with or
without chitin hydrolysate, Vector Laboratories, at a dilution of
1 in 10), ErCr lectin was used at a dilution of 1 in 3,000 (with or
without 200 mM lactose). The blots were washed extensively
after being incubated with the lectin solutions and were
incubated in streptavidin-HRP obtained from Sigma Aldrich
and diluted to 1 in 10,000. Bands were visualized using ECL
reagents as above.
Release, radiolabeling and analysis of TfR N-glycans
The N-glycans of the trypanosomal heterodimeric transferrin
receptor were released by PNGase-F and labeled with sodium
borotritiide following the method described in [28]. After extensive
cleanup steps to remove any contaminating tritiated material [28]
the
3H-labeled glycans were analyzed by HPTLC [Merck silica gel
60] and fractionated by HPAEC as described in [28] and fractions
were pooled according to the amount of radioactivity after 10%
was used for scintillation counting. Some of the pools were
digested using the broad specificity alpha mannosidase extracted
from Canavalia ensiformis (jack beans) (Sigma-Aldrich) and the a1-2
specific alpha mannosidase extracted from Aspergillus saitoi
(Prozyme), as described in [2]. After digestion the samples were
desalted using a mixed bed column as described in [2] and then
analyzed again by HTPLC as above. The HTPLC plates were run
3 times in butanol : methanol : water, 4 : 4 : 3 (v/v), with drying
between each run, then dried, sprayed with En
3Hance (Perkin
Elmer) and fluorographed with intensifying screens for up to 8
weeks at 280uC.
Analysis of TfR N-glycosylation site occupancy by LC-MS/
MS
Samples of transferrin receptor were digested with Endoglyco-
sidase H followed by PNGaseF digestion (Roche), then analyzed
by SDS-PAGE as above. Following staining with Simply Blue
(Sigma-Aldrich) the bands corresponding to ESAG6 and 7 were
cut out and subjected to proteomic analysis. An aliquot of the
tryptic digest was analyzed by LC-MS on an LTQ Orbitrap XL
(Thermo) using a Dionex 3000 Nano-LC as in [34]. The resulting
data were analyzed using Mascot and the T. brucei geneDB protein
database using variable modifications of N-acetylated glucosamine
modification of Asn, which would signify an Endoglycosidase H
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an Endoglycosidase H resistant site, as described in [34].
TfR overlay experiments
A ricin-binding total glycoprotein fraction from bloodstream
form T. brucei [27] was subjected to SDS-PAGE and transfer to
nitrocellulose. These blots were probed with tomato lectin (with
and without chitin hydrolysate inhibitor), as described above, or
with or without purified TfR (approximately 0.2 mg/ml in
phosphate buffered saline). The latter blots were subsequently
probed with anti-TfR antibody with ECL detection, as described
above.
Molecular modeling
Molecular modeling was performed on a Silicon Graphics Fuel
workstation using InsightII and Discover software (Accelrys Inc.,San
Diego, USA). Figures were produced using PyMol (The PyMOL
Molecular Graphics System, Schro ¨dinger, LLC). Protein structures
used for modeling were obtained from the pdb database [52].
The homology model of T. brucei TfR was based on crystal
structure of VSG MITat1.2 (pdb code - 1vsg [43]). The sequence
alignment between ESAG6, ESAG7 and VSG was based on [44],
modified to take account of the protein tertiary structure and the
additional disulphide bonds present. The formation of the
disulphide bonds in ESAG6 and ESAG7 between residues
equivalent to residues 62 and 286 in MITat1.2 required a
distortion of the helix starting at residue 61 and a rearrangement
of the loop-containing residue 286. The additional disulphide
bond in ESAG7 between residues equivalent to residues 203 and
220 in MITat1.2 could be accommodated with no alteration in the
secondary or tertiary protein structure. The model of VSG
MITat1.2 was based on the crystal structure of the N-terminal
domain (pdb code – 1vsg [43]) and the NMR structure of the C-
terminal domain (pdb code – 1xu6 [44]). The C-terminal domain
was placed directly below the N-terminal domain [44] to allow for
the dense packing of the N-terminal domains on the trypanosome
surface [48]. The linkers between the two domains and between
the C-terminal domain and the GPI anchor were modeled as
relatively compact random loops. The model of human transferrin
was based on the structure of iron-bound transferrin in complex
with the human transferrin receptor (pdb code – 1suv [45]), N-
linked and O-linked glycan structures and GPI anchors were
added to all models as appropriate. The structure of the glycans
were generated using the database of glycosidic linkage confor-
mations [52] and in vacuo energy minimisation to relieve
unfavorable steric interactions. The Asn-GlcNAc linkage confor-
mations were based on the observed range of crystallographic
values [53,54] the torsion angles around the Asn Ca-Cb and Cb-
Cc bonds then being adjusted to eliminate unfavorable steric
interactions between the glycans and the protein surface.
Accession numbers used in this study
The following GenBank protein sequence accession numbers
were used in this study: CAQ57442.1 and CAQ57441.1. The
following Protein Data Bank (pdb) files were used in this study:
1vsg, 1xu6, 1suv.
Supporting Information
Figure S1 Purified TfR does not react with tomato lectin (TL).
Aliquots of purified T. brucei TfR (lanes 1, 2, and 3) and of the T.
brucei ricin-binding glycoprotein fraction (a positive control for TL
blotting, lanes 4 and 5) were separated by SDS-PAGE, transferred
to nitrocellulose and subjected to blotting with anti-TfR antibody
(lane 1) or TL (lanes 2–5) in the absence (2) or presence (+) of the
TL inhibitor chitin hydrolysate. The positions of molecular weight
markers are indicated for each group of blots.
(DOC)
Figure S2 HPTLC analysis of N-glycans released from TfR and
labeled by NaB[
3H]4-reduction alongside known glycan standards
and structures released from other characterized glycoproteins. All
glycoprotein samples were treated with PNGaseF at the same time
and with the same reagents. Similarly, all glycan samples (derived
from glycoproteins and pure glycans supplied by Dextra Labs)
were reduced at the same time with the same reagents. Aliquots of
all radiolabeled total glycan fractions were separated on the same
HPTLC plate and detected by fluorography, as described in
Materials and Methods. The radiolabeled glycans were derived
from: bovine ribonuclease B (RNaseB) (lane 1), pure Man6-
GlcNAc2 (M6) (lane 2), pure Man8GlcNAc2 (M8) (lane 3), T. brucei
VSG MITat1.4 (lane 4), T. brucei TfR (lane5), T.brucei VSG
MITat1.7 (lane 6) and pure (Gal-GlcNAc)2Man3GlcNAc2 (NA2)
(lane 7). The sample in lane 5 is that shown in Figure 3A. Bovine
pancreatic ribonuclease B contains exclusively oligomannose
structures ranging from Man9GlcNAc2 to Man5GlcNAc2 (M9-
M5) [55] as does VSG MITat1.4 [6]. The assignments for the
VSG MITat1.7 glycans are based on the structures published by
Zamze et al. in [5].
(DOC)
Figure S3 Dionex HPAEC separation of radiolabeled N-
glycans. PNGase F-released and NaB
3H4-reduced N-glycans were
separated [28] by Dionex high-pH anion exchange chromatogra-
phy on a Dionex CarboPac PA-100 column (2 mm by 250 mm).
The column was equilibrated with 98% buffer A (100 mM NaOH)
and 2% buffer B (380 mM sodium acetate in 100 mM NaOH) for
20 min at a flow rate of 0.25 ml/min. N-glycans were separated
using a linear gradient of 2 to 25% buffer B over 40 min at
0.6 ml/min. The collection of 0.25 ml fractions was started after
3 min and aliquots (10%) of each were taken for liquid scintillation
counting. The fractions corresponding to peaks a, b and c are
indicated.
(DOC)
Table S1 CLUSTAL 2.1 multiple sequence alignment of 21 T.
brucei brucei ESAG6 sequences. The sequences in general and the
N-glycosylation sites (in bold) in particular are highly conserved in
the different ESAG6 family members.
(DOC)
Table S2 CLUSTAL 2.1 multiple sequence alignment of 14 T.
brucei brucei ESAG7 sequences. The sequences in general and the
N-glycosylation sites (in bold) in particular are highly conserved in
the different ESAG6 family members.
(DOC)
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